Orlando, Fla.—Regulatory, legislative and industry action is needed to ensure future drug shortages do not have the same crippling effect on health systems as the current scarcity of small-volume
Manufacturers need to be more transparent in their production details; regulators and producers should have better contingency plans in place; and electronic health records